Arcellx (ACLX) Accumulated Depreciation & Amortization (2021 - 2025)
Arcellx's quarterly Accumulated Depreciation & Amortization came in at $6.7 million in Q4 2025, up 28.85% year-on-year from $5.2 million in Q4 2024, and up 28.85% quarter-over-quarter from $5.2 million in Q4 2024.
Arcellx has reported Accumulated Depreciation & Amortization for 5 years, with the latest figure at $6.7 million in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 28.85% year-over-year to $6.7 million; the trailing twelve-month figure through Dec 2025 stood at $6.7 million (up 28.85% YoY), and the FY2025 full-year result was $6.7 million, up 28.85% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2025 stood at $6.7 million, up from $5.2 million in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $6.7 million in Q4 2025, with the low at $1.0 million in Q4 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $3.2 million, with a median of $2.0 million recorded in 2023.
- Year-over-year, Accumulated Depreciation & Amortization soared 160.0% in 2024 and gained 28.85% in 2025.
- Tracing ACLX's Accumulated Depreciation & Amortization over 5 years: stood at $1.0 million in 2021, then gained by 30.0% to $1.3 million in 2022, then surged by 53.85% to $2.0 million in 2023, then soared by 160.0% to $5.2 million in 2024, then advanced by 28.85% to $6.7 million in 2025.
- The last three Accumulated Depreciation & Amortization figures came in at $6.7 million (Q4 2025), $5.2 million (Q4 2024), and $2.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.70 Mn |
| Dec 31, 2025 | 6.70 Mn |
| Dec 31, 2024 | 5.20 Mn |
| Dec 31, 2024 | 5.20 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |